The former head of the federal office that will be at the forefront of developing a cure for COVID-19 said he was forced out after he prioritized science instead of promoting unproven treatments. Rick Bright told The New York Times he was removed as the director of the Biomedical Advanced Research and Development Authority (BARDA) because he limited the broad use of chloroquine and hydroxychloroquine, two drugs that President Trump repeatedly pushed as potential cures without evidence. |
Read the full story here |
Apr 2020